Seth Felder

Dr. Seth Felder


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2021 in Cancers
Verified
Journal Article
Open access
PDF file
CHCaroline Himbert
Caroline Himbert
JFJane C Figueiredo
Jane C Figueiredo
DSDavid Shibata
David Shibata
JOJennifer Ose
Jennifer Ose
TLTengda Lin
Tengda Lin
SHSheetal Hardikar
Sheetal Hardikar
Early-onset colorectal cancer has been on the rise in Western populations. Here, we compare patient characteristics between those with early- (<50 years) vs. late-onset (≥50 years) disease in a large multinational cohort of colorectal cancer patients (n = 2193). We calculated descriptive statistics and assessed associations of clinicodemographic factors with age of onset using mutually-adjusted logistic regression models. Patients were on average 60 years old, with BMI of 29 kg/m2, 52% colon cancers, 21% early-onset, and presented with stage II or III (60%) disease. Early-onset patients presented with more advanced disease (stages III–IV: 63% vs. 51%, respectively), and received more neo and adjuvant treatment compared to late-onset patients, after controlling for stage (odds ratio (OR) (95% confidence interval (CI)) = 2.30 (1.82–3.83) and 2.00 (1.43–2.81), respectively). Early-onset rectal cancer patients across all stages more commonly received neoadjuvant treatment, even when not indicated as the standard of care, e.g., during stage I disease. The odds of early-onset disease were higher among never smokers and lower among overweight patients (1.55 (1.21–1.98) and 0.56 (0.41–0.76), respectively). Patients with early-onset colorectal cancer were more likely to be diagnosed with advanced stage disease, to have received systemic treatments regardless of stage at diagnosis, and were less likely to be ever smokers or overweight.

1 April 2021 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
SFSeth Felder
Seth Felder
SPSujata Patil
Sujata Patil
EKErin Kennedy
Erin Kennedy
JGJulio Garcia-Aguilar
Julio Garcia-Aguilar

16 February 2021 in CA: A Cancer Journal for Clinicians
Verified
Journal Article
Open access
PDF file
ABAlec Bigness
Alec Bigness
IIIman Imanirad
Iman Imanirad
ISIbrahim Halil Sahin
Ibrahim Halil Sahin
HXHao Xie
Hao Xie
JFJessica Frakes
Jessica Frakes
SFSeth Felder
Seth Felder
CA: A Cancer Journal for Clinicians publishes information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and additional topics of interest related to cancer care.


24 March 2025 in Cancer Research
Verified
Journal Article
Closed access
MMMarco Matejcic
Marco Matejcic
JTJamie K. Teer
Jamie K. Teer
HHHannah J. Hoehn
Hannah J. Hoehn
DDDiana B. Diaz
Diana B. Diaz
KSKritika Shankar
Kritika Shankar
SSStephanie L. Schmit
Stephanie L. Schmit
Admixed populations, including the Hispanic/Latino/a community, are underrepresented in cancer genetic/genomic studies. Leveraging the Latino Colorectal Cancer Consortium (LC3) and other existing datasets, we analyzed whole-exome sequencing data on tumor/normal pairs from 718 individuals with colorectal cancer to map somatic mutational features by ethnicity and genetic similarity. Global proportions of African, Asian, European, and Native American genetic ancestries were estimated using ADMIXTURE. Associations between these proportions and somatic mutational features were examined using logistic regression. APC, TP53, and KRAS were the top three mutated genes across all participants and in the subset of Latino individuals in LC3. In analyses examining recurrently mutated genes, tumors from patients of Latino ethnicity had fewer KRAS and PIK3CA mutations compared with tumors from non-Latino patients. Genetic ancestry overall was associated with CDC27 mutation status, and African genetic ancestry was associated with SMAD2 mutation status. In exome-wide analyses, African genetic ancestry was significantly associated with higher odds of mutation in KNCN and TMEM184B. Native American genetic ancestry was associated with a lower frequency of microsatellite instability–high tumors. The SBS11 mutational signature was associated with Native American genetic ancestry as well as Latino ethnicity. In an independent replication dataset, MSK-IMPACT, estimates of association were largely consistent in direction but nonsignificant. A meta-analysis of LC3 and MSK-IMPACT showed that African genetic ancestry was significantly associated with KRAS mutation status and MSI status. This work facilitates precision medicine initiatives by providing insights into the contribution of genetic ancestry to molecular features of colorectal tumors. Significance: Analysis of tumors from various populations can broadly characterize genomic landscapes and enhance precision medicine strategies.

1 September 2021 in Clinical Colorectal Cancer
Verified
Journal Article
Closed access
SNSamer Naffouje
Samer Naffouje
ASArvind Sabesan
Arvind Sabesan
BPBenjamin Powers
Benjamin Powers
SDSophie Dessureault
Sophie Dessureault
JSJulian Sanchez
Julian Sanchez
SFSeth Felder
Seth Felder